Last checked at 14 Sep 2022 15:29
Craneware plc
("Craneware", the "Craneware Group", the "Company" or the "Group")
Change of Date of Final Results
14 September 2022 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, announces that due to the State Funeral of Her Majesty Queen Elizabeth II on 19th September 2022, it will now announce its results for the year ended 30 June 2022 on Tuesday 20th September.
For further information, please contact:
| |
Craneware plc | +44 (0)131 550 3100 |
Keith Neilson, CEO | |
Craig Preston, CFO | |
| |
Alma (Financial PR) | +44 (0)20 3405 0205 |
Caroline Forde, Hilary Buchanan, Joe Pederzolli | craneware@almapr.co.uk |
| |
Peel Hunt (NOMAD and Joint Broker) | +44 (0)20 7418 8900 |
Dan Webster, Andrew Clark | |
| |
Investec Bank PLC (Joint Broker) | +44 (0)20 7597 5970 |
Patrick Robb, Henry Reast, Sebastian Lawrence | |
| |
Berenberg (Joint Broker) | +44 (0)20 3207 7800 |
Mark Whitmore, Richard Andrews, Alix Mecklenburg-Solodkoff |
About Craneware
We at the Craneware Group of companies, including our latest additions Sentry Data Systems and Agilum Healthcare Intelligence, passionately believe we can impact healthcare profoundly by delivering the insights healthcare organizations need to also transform the business of healthcare. Our shared vision is to be the operational and financial partner for U.S. healthcare providers.
Our combined suite of applications and industry-leading team of experts help our customers contextualize operational, financial, and clinical data, providing insights that clearly demonstrate what great looks like. These value cycle insights deliver revenue integrity and 340B compliance, as well as margin and operational intelligence - something no other single partner can provide.
Together, approximately 40% of registered U.S. hospitals are now our customers, including more than 12,000 U.S hospitals, health systems and affiliated retail pharmacies and clinics. Our customers are operating with a financial impact of nearly half a trillion dollars. We have data sets from customers covering more than 150 million unique patients encounters.
Learn more at www.thecranewaregroup.com